Lucid Diligence Brief: Ultragenyx UX111 BLA resubmission
Lucid Diligence Brief: Ultragenyx UX111 BLA resubmission Professional audiences…
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled rare-disease therapeutics
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled…
Lucid Diligence Brief: Aurora Therapeutics launches to scale personalized CRISPR
Lucid Diligence Brief: Aurora Therapeutics launches to scale personalized…
Respiratory Today—January 9, 2026
This respiratory update spotlights reflects strong momentum across respiratory…
Lucid Diligence Brief: BioMarin to acquire Amicus Therapeutics for $4.8B
Lucid Diligence Brief: BioMarin to acquire Amicus Therapeutics for $4.8B…
Lucid Diligence Brief: Mirum to acquire Bluejay Therapeutics
Lucid Diligence Brief: Mirum to acquire Bluejay Therapeutics Professional…
Lucid Diligence Brief: Regeneron and Tessera team on TSRA-196 for AATD
Lucid Diligence Brief: Regeneron and Tessera team on TSRA-196 for AATD…
Lucid Diligence Brief: Protego Biopharma $130M Series B
Lucid Diligence Brief: Protego Biopharma $130M Series B Professional audiences…
Lucid Diligence Brief: Chiesi partners with Aliada (AbbVie) on BBB platform for LSDs
Lucid Diligence Brief: Chiesi partners with Aliada on BBB platform for LSDs…
Lucid Diligence Brief: Electra Therapeutics $183M Series C
Lucid Diligence Brief: Electra Therapeutics $183M Series C Professional…
Artificial Intelligence and Digital Health Weekly News - July 17th 2025
AI and Digital Health Update: Xealth Joins Samsung, ECG‑AI Stroke Alerts &…
Endocrinology Weekly Update - July 8th 2025
🧬 Endocrinology Update: Acromegaly Heart Breakthrough, AI in Diabetes, New…